Serial Number | 86835146 |
Word Mark | GAMAMABS |
Filing Date | Tuesday, December 1, 2015 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 8, 2019 |
Registration Number | 5876999 |
Registration Date | Tuesday, October 8, 2019 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 23, 2019 |
Goods and Services | Pharmaceutical preparations for the treatment of cancers and pharmaceutical preparations for the treatment of other proliferative diseases, namely, pharmaceuticals for the treatment of endometriosis, pharmaceuticals for the treatment of Polycystic Ovary Syndrome and pharmaceuticals for the treatment of tubal disease; monoclonal antibodies for the treatment of cancers and monoclonal antibodies for the treatment of other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, gene expression profiles or other molecular indicators or markers, namely, nucleic acid sequences and chemical reagents for medical purposes |
Pseudo Mark | GAMA ABS |
Goods and Services | Drug delivery devices, namely, drug delivery systems; injection devices for pharmaceutical preparations for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease; diagnostic devices, namely, biosensor analyzers for detecting cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, medical imaging apparatus for diagnosing cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, immunoanalyzers, namely, immunochemical testing equipment for medical use; medical testing equipment in the nature of medical instruments for analyzing and identifying bacteria in the nature of bacteriologic analyzers, for manual or for automated analysis for use in measuring or testing of biological samples in medical and clinical applications for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease |
Goods and Services | Chemical, biological and pharmaceutical research and development in the field of cancers and other proliferative diseases; conducting clinical trials for others in the field of cancers and other proliferative diseases |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 4, 2015 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 4, 2015 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 4, 2015 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | GamaMabs Pharma SA |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Toulouse Cedex 1 BP50624 FR |
Party Name | GamaMabs Pharma SA |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Toulouse Cedex 1 BP50624 FR |
Party Name | GamaMabs Pharma SA |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Toulouse Cedex 1 BP50624 FR |
Event Date | Event Description |
Wednesday, March 23, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, March 23, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Wednesday, March 23, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, March 23, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, October 8, 2019 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, July 23, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 23, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, July 3, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, June 19, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, June 19, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Tuesday, June 18, 2019 | CASE RETURNED TO EXAMINATION |
Friday, June 14, 2019 | NOTICE OF ALLOWANCE CANCELLED |
Friday, June 14, 2019 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
Friday, June 14, 2019 | ASSIGNED TO PETITION STAFF |
Friday, May 17, 2019 | TEAS PETITION TO AMEND BASIS RECEIVED |
Wednesday, December 19, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, December 17, 2018 | EXTENSION 2 GRANTED |
Monday, December 17, 2018 | EXTENSION 2 FILED |
Monday, December 17, 2018 | TEAS EXTENSION RECEIVED |
Friday, June 15, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, June 13, 2018 | EXTENSION 1 GRANTED |
Wednesday, June 13, 2018 | EXTENSION 1 FILED |
Wednesday, June 13, 2018 | TEAS EXTENSION RECEIVED |
Tuesday, January 2, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, November 7, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 7, 2017 | PUBLISHED FOR OPPOSITION |
Wednesday, October 18, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, September 29, 2017 | EXPARTE APPEAL TERMINATED |
Friday, September 29, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, September 28, 2017 | EXAMINER'S AMENDMENT ENTERED |
Thursday, September 28, 2017 | ASSIGNED TO LIE |
Thursday, September 28, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, September 28, 2017 | EXAMINERS AMENDMENT E-MAILED |
Thursday, September 28, 2017 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, September 26, 2017 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
Tuesday, September 26, 2017 | SUBSEQUENT FINAL EMAILED |
Tuesday, September 26, 2017 | SUBSEQUENT FINAL REFUSAL WRITTEN |
Tuesday, September 19, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, September 19, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, September 19, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, March 21, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, March 21, 2017 | NON-FINAL ACTION E-MAILED |
Tuesday, March 21, 2017 | NON-FINAL ACTION WRITTEN |
Thursday, March 2, 2017 | EX PARTE APPEAL-INSTITUTED |
Thursday, March 2, 2017 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
Thursday, March 2, 2017 | EXPARTE APPEAL RECEIVED AT TTAB |
Tuesday, February 28, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, February 28, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, February 28, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, February 28, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, February 28, 2017 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Tuesday, February 28, 2017 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Friday, September 2, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Friday, September 2, 2016 | FINAL REFUSAL E-MAILED |
Friday, September 2, 2016 | FINAL REFUSAL WRITTEN |
Wednesday, August 31, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, August 30, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, August 30, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, March 21, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, March 21, 2016 | NON-FINAL ACTION E-MAILED |
Monday, March 21, 2016 | NON-FINAL ACTION WRITTEN |
Sunday, March 20, 2016 | ASSIGNED TO EXAMINER |
Saturday, December 5, 2015 | NOTICE OF PSEUDO MARK E-MAILED |
Friday, December 4, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Friday, December 4, 2015 | NEW APPLICATION ENTERED IN TRAM |